Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund and Insider Trading News: Ray Dalio, Kyle Bass, Neil Woodford, Elliott Management, Otelco Inc (OTEL), ResMed Inc. (RMD), and More

Wednesday 7/17 Insider Buying Report: OTEL, REZI (Nasdaq.com)
At Otelco (OTEL), a filing with the SEC revealed that on Monday, Ira Sochet bought 4,874 shares of OTEL, at a cost of $14.53 each, for a total investment of $70,838. Otelco is trading off about 2.5% on the day Wednesday. Before this latest buy, Sochet purchased OTEL on 21 other occasions during the past year, for a total investment of $7.19M at an average of $15.96 per share. And at Resideo Technologies (REZI), there was insider buying on Monday, by CEO Michael G. Nefkens who purchased 467 shares at a cost of $21.40 each, for a total investment of $9,994. Before this latest buy, Nefkens purchased REZI at 7 other times during the past twelve months, for a total investment of $355,166 at an average of $20.54 per share. Resideo Technologies is trading down about 1.4% on the day Wednesday. Bargain hunters are able to snag REZI at a price even lower than Nefkens did, with shares changing hands as low as $19.64 at last check today which is 8.2% under Nefkens’s purchase price.

Resmed Inc (RMD) President and COO ResMed Inc. Robert Andrew Douglas Sold $511,820 of Shares (Guru Focus)
President and COO ResMed Inc. of Resmed Inc (30-Year Financial, Insider Trades) Robert Andrew Douglas (insider trades) sold 4,111 shares of RMD on 07/15/2019 at an average price of $124.5 a share. The total sale was $511,820. ResMed Inc is a part of the healthcare sector. It develops and distributes medical products for treating and diagnosing respiratory disorders. ResMed Inc has a market cap of $17.78 billion; its shares were traded at around $123.97 with a P/E ratio of 40.26 and P/S ratio of 7.08. The dividend yield of ResMed Inc stocks is 1.20%. ResMed Inc had annual average EBITDA growth of 12.40% over the past ten years. GuruFocus rated ResMed Inc the business predictability rank of 3.5-star. GuruFocus has detected 3 severe warning signs with ResMed Inc.

Insider Trading: Overreach, Underreach and Reform (Law.com)
It has been nearly 60 years since the SEC first clearly prohibited insider trading in its 1961 decision in In re Cady, Roberts & Co. You would think that would be long enough for the doctrinal rules to have become reasonably clear. Think again! The recent evidence shows otherwise: A month ago, U.S. District Judge Paul Gardephe for the Southern District of New York permitted a defendant who had plead guilty to insider trading charges in 2013 to withdraw his guilty plea because there had been “insufficient” evidence that a personal benefit had been paid by the tippee to the tipper.

Nike Inc (NKE) EVP, CAO & General Counsel Hilary K Krane Sold $1.6 million of Shares (Guru Focus)
EVP, CAO & General Counsel of Nike Inc (30-Year Financial, Insider Trades) Hilary K Krane (insider trades) sold 17,903 shares of NKE on 07/12/2019 at an average price of $88.7 a share. The total sale was $1.6 million. Nike Inc designs, develops and markets footwear, apparel, equipment, and accessory products. It is a seller of athletic footwear and athletic apparel. It sells its products through NIKE-owned in-line and factory retail stores and internet websites. Nike Inc has a market cap of $139.26 billion; its shares were traded at around $88.60 with a P/E ratio of 35.58 and P/S ratio of 3.71. The dividend yield of Nike Inc stocks is 0.96%. Nike Inc had annual average EBITDA growth of 10.30% over the past ten years. GuruFocus rated Nike Inc the business predictability rank of 5-star.

The CFO of GSI Technology is Exercising Options (Analyst Ratings)
Yesterday it was reported that the CFO of GSI Technology (GSIT), Douglas Schirle, exercised options to buy 2,625 GSIT shares at $4.00 a share, for a total transaction value of $10.5K. The options were close to expired and Douglas Schirle retained stocks. Following this transaction Douglas Schirle’s holding in the company was increased by 5.51% to a total of $381.6K. Following Douglas Schirle’s last GSIT Buy transaction on June 25, 2018, the stock climbed by 0.8%.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...